Table 1 Baseline characteristics of the population comparing patients with metabolic syndrome (MS) and without MS
Parameter | With MS | Without MS | p |
|---|---|---|---|
(n = 30) | (n = 90) | ||
Age (years) | 35 (26–42) | 28 (20–34) | 0.002* |
Evolution of T1D (years) | 20 (14.7–28) | 16 (11–25) | 0.051 |
Gender | |||
Female | 26% | 74% | 0.584 |
Male | 12% | 88% | |
Smoking status | 5% | 18% | 0.551 |
Insulin dose (U/day) | 49 (40–69.8) | 45.5 (39–57) | 0.086* |
(U/kg/day) | 0.69 (0.52–0.98) | 0.75 (0.59–0.97) | 0.974 |
Weight (m) | 1.62 (1.57–1.70) | 1.66 (1.55–1.67) | 0.269 |
BMI (kg/m2) | 25 (23.8–28.7) | 23.3 (21.3–26.4) | 0.004* |
WC (cm) | 90.4 ± 10.7 | 79.6 ± 8.2 | <0.01† |
Male | 92.1 ± 12.6 | 85.2 ± 6.1 | 0.032 |
Female | 89.6 ± 10.3 | 77.2 ± 7.88 | <0.01 |
WHtR | 0.54 (0.51–0.60) | 0.49 (0.46–0.53) | <0.001* |
Hypertension | 14% | 8% | <0.01‡ |
Dyslipidemia | 18% | 16% | 0.02‡ |
Glycated hemoglobin (%) | 8.8 (8–10) | 8.2 (7.5–9.3) | 0.036* |
Total colesterol (mg/dl) | 188 (169–210) | 174.5 (153–206) | <0.012* |
Tryglycerides (mg/dl) | 175 (136–248) | 88 (66–113) | <0.01* |
c-HDL (mg/dl) | 46 (37–53) | 57 (48–66) | <0.01* |
Male | 41 (37–48) | 49 (44–60) | 0.044 |
Female | 47 (37–55) | 60 (53–69) | <0.01 |